These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 9972509)
21. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors. Shields CL; Mashayekhi A; Cater J; Shelil A; Meadows AT; Shields JA Trans Am Ophthalmol Soc; 2004; 102():35-44; discussion 44-5. PubMed ID: 15747743 [TBL] [Abstract][Full Text] [Related]
22. Conservative treatment modalities in retinoblastoma. Chawla B; Jain A; Azad R Indian J Ophthalmol; 2013 Sep; 61(9):479-85. PubMed ID: 24104705 [TBL] [Abstract][Full Text] [Related]
23. The outcome of chemoreduction treatment in patients with Reese-Ellsworth group V retinoblastoma. Gündüz K; Shields CL; Shields JA; Meadows AT; Gross N; Cater J; Needle M Arch Ophthalmol; 1998 Dec; 116(12):1613-7. PubMed ID: 9869790 [TBL] [Abstract][Full Text] [Related]
24. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma. Shields CL; Honavar SG; Shields JA; Demirci H; Meadows AT; Naduvilath TJ Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319 [TBL] [Abstract][Full Text] [Related]
25. Modern treatment of retinoblastoma: A 2020 review. Ancona-Lezama D; Dalvin LA; Shields CL Indian J Ophthalmol; 2020 Nov; 68(11):2356-2365. PubMed ID: 33120616 [TBL] [Abstract][Full Text] [Related]
26. Treatment of Retinoblastoma in 2015: Agreement and Disagreement. Abramson DH; Shields CL; Munier FL; Chantada GL JAMA Ophthalmol; 2015 Nov; 133(11):1341-7. PubMed ID: 26378747 [TBL] [Abstract][Full Text] [Related]
27. Management of intraocular retinoblastoma and ocular prognosis. Suzuki S; Kaneko A Int J Clin Oncol; 2004 Feb; 9(1):1-6. PubMed ID: 15162819 [TBL] [Abstract][Full Text] [Related]
32. [Diode laser thermotherapy and chemothermotherapy in the treatment of retinoblastoma]. Lumbroso L; Doz F; Levy C; Dendale R; Vedrenne J; Bours D; Zucker JM; Asselain B; Desjardins L J Fr Ophtalmol; 2003 Feb; 26(2):154-9. PubMed ID: 12660589 [TBL] [Abstract][Full Text] [Related]
33. Clinical efficacy and prognostic factors of chemoreduction combined with topical treatment for advanced intraocular retinoblastoma. Liu Y; Zhang X; Liu F; Wang KL Asian Pac J Cancer Prev; 2014; 15(18):7805-9. PubMed ID: 25292067 [TBL] [Abstract][Full Text] [Related]
34. [Results of combined chemotherapy and local ophtalmic therapy of children with intraocular retinoblastoma]. Balwierz W; Kobylarz J; Starzycka M; Dluzniewska A Med Wieku Rozwoj; 2001; 5(3 Suppl 1):15-23. PubMed ID: 12004148 [TBL] [Abstract][Full Text] [Related]
35. Eye-Preserving Therapies for Advanced Retinoblastoma: A Multicenter Cohort of 1678 Patients in China. Zhou C; Wen X; Ding Y; Ding J; Jin M; Liu Z; Wang S; Han M; Yuan H; Xiao Y; Wu L; Wang J; Li Y; Yu J; Wen Y; Ye J; Liu R; Chen Z; Xue S; Lu W; Liao H; Cui J; Zhu D; Lu F; Tang S; Wu Y; Yangkyi T; Zhang G; Wubuli M; Guo H; Wang X; He Y; Sheng X; Wang Q; Luo Y; Fan J; Qi J; Yu Z; Tan J; Liang J; Sun X; Jin L; Yang X; Zhang J; Ji X; Zhao J; Jia R; Fan X Ophthalmology; 2022 Feb; 129(2):209-219. PubMed ID: 34536465 [TBL] [Abstract][Full Text] [Related]
36. Chemoreduction in the management of retinoblastoma. Shields JA; Shields CL; Meadows AT Am J Ophthalmol; 2005 Sep; 140(3):505-6. PubMed ID: 16139001 [No Abstract] [Full Text] [Related]
37. Therapeutic Options for Retinoblastoma. Mendoza PR; Grossniklaus HE Cancer Control; 2016 Apr; 23(2):99-109. PubMed ID: 27218786 [TBL] [Abstract][Full Text] [Related]
38. Treatment of retinoblastoma patients with chemoreduction plus local therapy: experience of the AC Camargo Hospital, Brazil. Antoneli CB; Ribeiro KC; Steinhorst F; Novaes PE; Chojniak MM; Malogolowkin M J Pediatr Hematol Oncol; 2006 Jun; 28(6):342-5. PubMed ID: 16794500 [TBL] [Abstract][Full Text] [Related]
39. Diagnosis and management of retinoblastoma. Shields CL; Shields JA Cancer Control; 2004; 11(5):317-27. PubMed ID: 15377991 [TBL] [Abstract][Full Text] [Related]
40. Risk Factors for Tumor Recurrence Following Primary Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma in 869 Eyes of 551 Patients. Dalvin LA; Bas Z; Tadepalli S; Rao R; Vaidya S; Pacheco R; Shields CL J Pediatr Ophthalmol Strabismus; 2020 Jul; 57(4):224-234. PubMed ID: 32687206 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]